Cassiopea reports that shareholders approve all agenda items at annual shareholders meeting
Lainate - February 24, 2017 - Cassiopea S.p.A. (SIX: SKIN), a clinical stage specialty pharmaceutical company focused on developing innovative and differentiated medical dermatology products, today announced that shareholders approved the financial statements 2016 at the general shareholders meeting in Lainate.
Shareholders representing 5'279'833 shares unanimously approved the financial statements 2016. No other items were on the agenda.
Provider | Channel | Contact | ||
---|---|---|---|---|
Tensid EQS Ltd., Switzerland www.tensid.ch |
newsbox.ch www.newsbox.ch |
Provider/Channel related enquiries marco@tensid.ch +41 41 763 00 50 |